Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Susan_Dillon
|
| gptkbp:focusesOn |
centyrin-based therapeutics
|
| gptkbp:foundedBy |
gptkb:Karyn_O'Neil
gptkb:Susan_Dillon |
| gptkbp:foundedYear |
2018
|
| gptkbp:headquartersLocation |
gptkb:Philadelphia,_Pennsylvania,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aro Biotherapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Centyrins
|
| gptkbp:platform |
Centyrin platform
|
| gptkbp:specializesIn |
protein therapeutics
targeted drug delivery |
| gptkbp:website |
https://www.arobiotx.com/
|
| gptkbp:bfsParent |
gptkb:Nessan_Bermingham
|
| gptkbp:bfsLayer |
7
|